LYSERGIC ACID DIETHYLAMIDE (LSD)

Course overview

LYSERGIC ACID DIETHYLAMIDE (LSD) IS A CLASSICAL HALLUCINOGEN. NO APPROVED INDICATIONS FOR LSD-ASSISTED THERAPY EXIST TODAY. IT HAS BEEN USED IN THE PAST FOR NON-FDA APPROVED INDICATIONS: DEPRESSIVE DISORDERS INCLUDING THOSE WITH CONVERSION PHOBIA, NEUROSIS, MANIC-DEPRESSION, AND REACTIVE DEPRESSION, CYCLOTHYMIC (OBSESSIONAL) AND PASSIVE-AGGRESSIVE (OBSESSIONAL) COMPULSIVE SEXUAL DEVIATION ADDICTION, PSYCHONEUROTIC DISORDERS, MIXED, PAN-NEUROTICISM (INCLUDING SCHIZOPHRENIA), BORDERLINE OR LATENT AND PERSONALITY DISORDERS (ESPECIALLY TRANSIENT SITUATIONAL). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE/TOXICITY, PHARMACOLOGY, MONITORING, AND RELEVANT INTERACTIONS OF LSD, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM SHOULD THEY ENCOUNTER PATIENTS WHO MISUSE OR HAVE MISUSED THIS DRUG.